{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T12:28:24Z","timestamp":1751891304259},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>The pineal parenchymal tumors of intermediate differentiation (PPTIDs) are extremely rare tumor entities. They exhibit low-risk (grade II) and high-risk (grade III) malignancies, which may lead to different therapies and prognosis. However, the histological grading criteria remains elusive, and novel biomarkers may be helpful to differentiate the grade of PPTIDs. Immunohistochemical staining for CD24, PRAME, POU4F2, and HOXD13, and their clinicopathologic analyses were performed in pineal parenchymal tumors and other tumors in the pineal region. CD24 and PRAME were expressed in 9\/11 (81.8%) and 8\/11(72.7%) cases of PPTIDs grade III, compared with 6\/18 (33.3%) and 5\/18(27.8%) cases of PPTIDs grade II. The levels of CD24 and PRAME were significantly higher in PPTIDs grade III than grade II. However, there were no differences of HOXD13 and POU4F2 expression levels in PPTIDs grade II and grade III. Interestingly, high expression of CD24 and PRAME were prevalently found in high-grade tumors of the central nervous system. In addition, PPTIDs patients with high expression levels of CD24 and PRAME exhibited a significant shorter survival time. The results of PPTIDs grading by CD24 and PRAME were mostly consistent with WHO criteria, except for two cases. According to the prognostic information of patients, we found that the combination of CD24 and PRAME expression for grading PPTIDs might be more valuable than WHO criteria only. CD24 and PRAME are novel markers for grading and prognostic evaluation of PPTIDs that may be helpful to determine the therapeutic decision for PPTIDs patients.<\/jats:p>","DOI":"10.1097\/pas.0000000000001350","type":"journal-article","created":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T21:26:36Z","timestamp":1569187596000},"page":"11-20","source":"Crossref","is-referenced-by-count":16,"title":["CD24 and PRAME Are Novel Grading and Prognostic Indicators for Pineal Parenchymal Tumors of Intermediate Differentiation"],"prefix":"10.1097","volume":"44","author":[{"given":"Xuehui","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Pathology, Nanfang Hospital, Southern Medical University"},{"name":"Department of Pathology, Southern Medical University"},{"name":"Guangdong Province Key Laboratory of Molecular Tumor Pathology"},{"name":"Department of Pathology, the People\u2019s Hospital of China Three Gorges University, Yichang, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nanfang Hospital, Southern Medical University"},{"name":"General Hospital of Southern Theater Command, People\u2019s Liberation Army of China, Guangzhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangmeng","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nanfang Hospital, Southern Medical University"},{"name":"Department of Pathology, Southern Medical University"},{"name":"Guangdong Province Key Laboratory of Molecular Tumor Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangshu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nanfang Hospital, Southern Medical University"},{"name":"Department of Pathology, Southern Medical University"},{"name":"Guangdong Province Key Laboratory of Molecular Tumor Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nanfang Hospital, Southern Medical University"},{"name":"Department of Pathology, Southern Medical University"},{"name":"Guangdong Province Key Laboratory of Molecular Tumor Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaoying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nanfang Hospital, Southern Medical University"},{"name":"Department of Pathology, Southern Medical University"},{"name":"Guangdong Province Key Laboratory of Molecular Tumor Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunshi","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nanfang Hospital, Southern Medical University"},{"name":"Department of Pathology, Southern Medical University"},{"name":"Guangdong Province Key Laboratory of Molecular Tumor Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nanfang Hospital, Southern Medical University"},{"name":"Department of Pathology, Southern Medical University"},{"name":"Guangdong Province Key Laboratory of Molecular Tumor Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nanfang Hospital, Southern Medical University"},{"name":"Department of Pathology, Southern Medical University"},{"name":"Guangdong Province Key Laboratory of Molecular Tumor Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nanfang Hospital, Southern Medical University"},{"name":"Department of Pathology, Southern Medical University"},{"name":"Guangdong Province Key Laboratory of Molecular Tumor Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nanfang Hospital, Southern Medical University"},{"name":"Department of Pathology, Southern Medical University"},{"name":"Guangdong Province Key Laboratory of Molecular Tumor Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"key":"R1-20230922","first-page":"907","article-title":"Pineal region tumors and the role of stereotactic biopsy: review of the mortality, morbidity, and diagnostic rates in 370 cases","volume":"39","author":"Regis","year":"1996","journal-title":"Neurosurgery"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/PAP.0b013e3181f895a4","article-title":"Pineal tumors","volume":"17","author":"Dahiya","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.nec.2011.05.006","article-title":"Pathology of pineal parenchymal tumors","volume":"22","author":"Han","year":"2011","journal-title":"Neurosurg Clin N Am"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/jnnp-2014-309805","article-title":"Twenty-seven cases of pineal parenchymal tumours of intermediate differentiation: mitotic count, Ki-67 labelling index and extent of resection predict prognosis","volume":"87","author":"Yu","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.radonc.2016.10.025","article-title":"Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: an individual patient data analysis","volume":"121","author":"Mallick","year":"2016","journal-title":"Radiother Oncol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3892\/mco.2013.231","article-title":"Pineal parenchymal tumor of intermediate differentiation: treatment outcomes of five cases","volume":"2","author":"Watanabe","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1748-717X-5-122","article-title":"Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003\u2014a single institution\u2019s experience","volume":"5","author":"Stoiber","year":"2010","journal-title":"Radiat Oncol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000210051","article-title":"Occipital transtentorial approach and combined treatments for pineal parenchymal tumors","volume":"23","author":"Tsumanuma","year":"2009","journal-title":"Prog Neurol Surg"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40064-015-1502-9","article-title":"Are we over treating pineal parenchymal tumour with intermediate differentiation? Assessing the role of localised radiation therapy and literature review","volume":"5","author":"Das","year":"2016","journal-title":"Springerplus"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0360-3016(99)00389-2","article-title":"Parenchymal pineal tumors: a clinicopathological study of 76 cases","volume":"46","author":"Fauchon","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1750-3639.2000.tb00242.x","article-title":"Pineal parenchymal tumors: a correlation of histological features with prognosis in 66 cases","volume":"10","author":"Jouvet","year":"2000","journal-title":"Brain Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5414\/NPP27325","article-title":"Pineal parenchymal tumors\u2014utility of immunohistochemical markers in prognostication","volume":"27","author":"Arivazhagan","year":"2008","journal-title":"Clin Neuropathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1177\/147323001103900434","article-title":"Pineal parenchymal tumours: minimum apparent diffusion coefficient in prediction of tumour grading","volume":"39","author":"Zhu","year":"2011","journal-title":"J Int Med Res"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10014-012-0089-x","article-title":"Pineal parenchymal tumor of intermediate differentiation with marked elevation of MIB-1 labeling index","volume":"29","author":"Fukuoka","year":"2012","journal-title":"Brain Tumor Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.wneu.2013.02.007","article-title":"Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation","volume":"81","author":"Ito","year":"2014","journal-title":"World Neurosurg"},{"key":"R16-20230922","first-page":"481","article-title":"Pineal parenchymal tumor with marked cytologic pleomorphism: is there a correlation with the malignancy grade?","volume":"44","author":"Ito","year":"2016","journal-title":"No Shinkei Geka"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/neuonc\/now105","article-title":"Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome","volume":"19","author":"Raleigh","year":"2017","journal-title":"Neuro Oncol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/01.jnen.0000225907.90052.e3","article-title":"Microarray analysis reveals differential gene expression patterns in tumors of the pineal region","volume":"65","author":"Fevre-Montange","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"R19-20230922","first-page":"8","article-title":"Pathological and immunohistochemical study of pineal parenchymal tumors","volume":"31","author":"Fang","year":"2002","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/PAS.0b013e3181a13eef","article-title":"SALL4 is a novel diagnostic marker for testicular germ cell tumors","volume":"33","author":"Cao","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/path.2668","article-title":"A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer","volume":"220","author":"Hao","year":"2010","journal-title":"J Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/PAS.0000000000000951","article-title":"Diagnostic utility of SATB2 in metastatic krukenberg tumors of the ovary: an immunohistochemical study of 70 cases with comparison to CDX2, CK7, CK20, chromogranin, and synaptophysin","volume":"42","author":"Yang","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/PAI.0000000000000565","article-title":"Pathologic prognostic factors of pineal parenchymal tumor of intermediate differentiation","volume":"27","author":"Chatterjee","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2990.2011.01202.x","article-title":"Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study","volume":"38","author":"Fevre-Montange","year":"2012","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/PAI.0000000000000565","article-title":"Pathologic prognostic factors of pineal parenchymal tumor of intermediate differentiation","volume":"27","author":"Chatterjee","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/1097-0142(19930801)72:3<870::AID-CNCR2820720336>3.0.CO;2-X","article-title":"Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects","volume":"72","author":"Schild","year":"1993","journal-title":"Cancer"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF00310377","article-title":"Structural and ultrastructural characteristics of human pineal gland, and pineal parenchymal tumors","volume":"88","author":"Jouvet","year":"1994","journal-title":"Acta Neuropathol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0046-8177(95)90110-8","article-title":"Tumors of pineal parenchymal cells: a correlation of histological features, including nucleolar organizer regions, with survival in 35 cases","volume":"26","author":"Mena","year":"1995","journal-title":"Hum Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00401-019-01990-5","article-title":"Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma","volume":"137","author":"Lee","year":"2019","journal-title":"Acta Neuropathol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"638","DOI":"10.4049\/jimmunol.144.2.638","article-title":"Signal transduction in lymphocytic and myeloid cells via CD24, a new member of phosphoinositol-anchored membrane molecules","volume":"144","author":"Fischer","year":"1990","journal-title":"J Immunol"},{"issue":"suppl 2","key":"R31-20230922","doi-asserted-by":"crossref","first-page":"S351","DOI":"10.1016\/S0753-3322(05)80076-9","article-title":"CD24 and human carcinoma: tumor biological aspects","volume":"59","author":"Lim","year":"2005","journal-title":"Biomed Pharmacother"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1038\/s41598-018-22220-0","article-title":"Author correction: unraveling the roles of CD44\/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis","volume":"8","author":"Li","year":"2018","journal-title":"Sci Rep"},{"key":"R33-20230922","first-page":"313","article-title":"The prognostic role of cancer stem cell markers for long-term outcome after resection of colonic liver metastases","volume":"38","author":"Spelt","year":"2018","journal-title":"Anticancer Res"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1007\/s13277-015-4442-7","article-title":"CD24 promotes HCC progression via triggering Notch-related EMT and modulation of tumor microenvironment","volume":"37","author":"Wan","year":"2016","journal-title":"Tumour Biol"},{"key":"R35-20230922","first-page":"2215","article-title":"CD24 and Nanog expression in stem cells in glioblastoma: correlation with response to chemoradiation and overall survival","volume":"18","author":"Soni","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/mc.22522","article-title":"CD24 is a genetic modifier for risk and progression of prostate cancer","volume":"56","author":"Zhang","year":"2017","journal-title":"Mol Carcinog"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000491667","article-title":"CD24 is a potential biomarker for prognosis in human breast carcinoma","volume":"48","author":"Jing","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/cas.13435","article-title":"Downregulation of CD24 suppresses bone metastasis of lung cancer","volume":"109","author":"Okabe","year":"2018","journal-title":"Cancer Sci"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.1158\/0008-5472.CAN-04-1442","article-title":"Intratumor heterogeneity of cancer\/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2\u2019-deoxycytidine","volume":"64","author":"Sigalotti","year":"2004","journal-title":"Cancer Res"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.bjc.6602779","article-title":"Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability","volume":"93","author":"Smith","year":"2005","journal-title":"Br J Cancer"},{"key":"R42-20230922","first-page":"2","article-title":"Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformatics","volume":"5","author":"Segal","year":"2005","journal-title":"Cancer Immun"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13569-017-0077-3","article-title":"Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes","volume":"7","author":"Roszik","year":"2017","journal-title":"Clin Sarcoma Res"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1158\/1078-0432.CCR-03-0813","article-title":"The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome","volume":"10","author":"Oberthuer","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/hed.20380","article-title":"Expression of cancer testis antigens in head and neck squamous cell carcinomas","volume":"28","author":"Figueiredo","year":"2006","journal-title":"Head Neck"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1046\/j.1365-2141.1998.00982.x","article-title":"PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells","volume":"102","author":"van Baren","year":"1998","journal-title":"Br J Haematol"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2005.07.003","article-title":"The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling","volume":"122","author":"Epping","year":"2005","journal-title":"Cell"},{"key":"R48-20230922","first-page":"10716","article-title":"HOXD13 methylation status is a prognostic indicator in breast cancer","volume":"8","author":"Zhong","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R49-20230922","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/ijc.24438","article-title":"HOX D13 expression across 79 tumor tissue types","volume":"125","author":"Cantile","year":"2009","journal-title":"Int J Cancer"},{"key":"R50-20230922","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.onc.1210621","article-title":"Proliferation-associated Brn-3b transcription factor can activate cyclin D1 expression in neuroblastoma and breast cancer cells","volume":"27","author":"Budhram-Mahadeo","year":"2008","journal-title":"Oncogene"},{"key":"R51-20230922","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1158\/0008-5472.CAN-17-3140","article-title":"Adoptive immunotherapy using PRAME-specific T cells in medulloblastoma","volume":"78","author":"Orlando","year":"2018","journal-title":"Cancer Res"},{"key":"R52-20230922","doi-asserted-by":"crossref","first-page":"e0191244","DOI":"10.1371\/journal.pone.0191244","article-title":"Comprehensive molecular profiling of advanced\/metastatic olfactory neuroblastomas","volume":"13","author":"Topcagic","year":"2018","journal-title":"PLoS One"},{"key":"R53-20230922","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1038\/sj.onc.1207043","article-title":"Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes","volume":"22","author":"Boon","year":"2003","journal-title":"Oncogene"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:51:07Z","timestamp":1695423067000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001350","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,20]]}}}